Effect of integrated traditional Chinese and Western medicine on SARS: A review of clinical evidence

Table 2 Results of meta-analysis of integrated traditional Chinese and Western medicine for SARS at the end of treatment

Comparison or outcomes	Study	Participants			Statistical method	Effect estimate
		Total	Trial	Control
National drugs No.2.3.4 combined with Western medicine versus Western medicine
Mortality	Wang RB 2003	65	1/35	2/30	RR (fixed) 95%	0.41 (0.04, 4.78)
Lung infiltrate absorption		53	25/30	11/23		5.45 (1.54, 19.26)
The secondary infection		65	4/35	7/30		0.42 (0.11, 1.62)
Compound formulas No.1 combined with Western medicine versus Western medicine
Symptom improvement integral	Jiang ZY 2003	40	7.90 (5.81)	6.50 (3.83)	WMD (fixed) 95%	1.40 (-1.65, 4.45)
Lung infiltrate absorption		40	0.65 (0.35)	0.38 (0.37)		0.24 (0.02, 0.46)
Quality of life integral		40	19.93 (3.69)	22.10 (4.90)		-2.17 (-4.86, 0.52)
Compound formulas combined with Western medicine versus Western medicine
Lung infiltrate absorption	Wang BN 2003	59	30/30	26/29	RR (fixed) 95%	8.06 (0.40, 163.21)
Kangfeidian No.4 combined with Western medicine versus Western medicine
Loss of dyspnea	Zhang SN 2003	38	12/20	9/18	RR (fixed) 95%	1.50 (0.41, 5.43)
Loss of cough		30	9/16	7/14		1.29 (0.30, 5.43)